Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

fl uoroquinolones. Fever takes median 5–7d to respond due to intracellular niche of organism. Antipyretics, fl uid management, nutrition. CNS disease: dexametha- sone 3mg/kg IV then 1mg/kg/6h for 8 doses (limited data). Vaccine: Ty21a (oral, live, CI: immunosuppression, pregnancy) or Vi (IM, capsular vaccine). ~50–80% eff ective for ~3yr. Limited/no protection against paratyphoid. __OOHHCCMM__1100ee..iinnddbb 441155 0022//0055//22001177 1199::0077 sesaesid suoitcefnI 416 Malaria: diagnosis Epidemiology • 3.2 billion people at risk in 95 countries = half the world’s population (fi g 9.23). • 214 million/cases per year with 438 000 deaths. • Sub-Saharan Africa: 88% of malaria cases, 90% of deaths (most age <5yr). • Most common tropical disease imported into UK, ~2000 cases/yr. • ~20% fever in travellers from Africa presenting to UK hospitals is due to malaria. • Plasmodium falciparum is the most prevalent parasite in Africa and responsible for most malaria deaths worldwide (=~75% of malaria presenting in UK). • Plasmodium vivax is the dominant parasite outside of sub-Saharan Africa. • Preventable and treatable: incidence  by 37% and deaths  by 60% since 2000. Malaria parasites Malaria parasites belong to the genus Plasmodium. >100 species exist of which 5 cause human disease (see table 9.19). Transmission occurs through
